GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Dabomb Protein Biotech Corp (ROCO:6578) » Definitions » Scaled Net Operating Assets

Dabomb Protein Biotech (ROCO:6578) Scaled Net Operating Assets : 0.67 (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Dabomb Protein Biotech Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Dabomb Protein Biotech's operating assets for the quarter that ended in Mar. 2024 was NT$976.2 Mil. Dabomb Protein Biotech's operating liabilities for the quarter that ended in Mar. 2024 was NT$35.0 Mil. Dabomb Protein Biotech's Total Assets for the quarter that ended in Dec. 2023 was NT$1,401.9 Mil. Therefore, Dabomb Protein Biotech's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 0.67.


Dabomb Protein Biotech Scaled Net Operating Assets Historical Data

The historical data trend for Dabomb Protein Biotech's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dabomb Protein Biotech Scaled Net Operating Assets Chart

Dabomb Protein Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.77 0.74 0.97 0.74 0.74

Dabomb Protein Biotech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.78 0.71 0.60 0.65 0.67

Competitive Comparison of Dabomb Protein Biotech's Scaled Net Operating Assets

For the Packaged Foods subindustry, Dabomb Protein Biotech's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dabomb Protein Biotech's Scaled Net Operating Assets Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Dabomb Protein Biotech's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Dabomb Protein Biotech's Scaled Net Operating Assets falls into.



Dabomb Protein Biotech Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Dabomb Protein Biotech's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(972.442-25.831)/1280.086
=0.74

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=1401.896 - 429.454
=972.442

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=443.833 - 86.337 - 331.665
=25.831

Dabomb Protein Biotech's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2024 )
=(Operating Assets (Q: Mar. 2024 )-Operating Liabilities (Q: Mar. 2024 ))/Total Assets (Q: Dec. 2023 )
=(976.224-34.958)/1401.896
=0.67

where

Operating Assets(Q: Mar. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=1400.002 - 423.778
=976.224

Operating Liabilities(Q: Mar. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=387.54 - 76.282 - 276.3
=34.958

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dabomb Protein Biotech Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Dabomb Protein Biotech's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Dabomb Protein Biotech (ROCO:6578) Business Description

Traded in Other Exchanges
N/A
Address
Number 52, Gongye 3rd Road, Annan District, Tainan, TWN, 709
Dabomb Protein Biotech Corp is a company specializing in antibiotic alternatives, and use postbiotics to boost immune strength and excel in innovative fermentation for improved plant protein utility. Their portfolio of products which include DBT-100 LS and DBT-100 HT , Liqui-TIDE bandage and LACTOTIDES HEALTH A+.

Dabomb Protein Biotech (ROCO:6578) Headlines

No Headlines